AJP - Renal AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 258: F1036-F1041, 1990;
0363-6127/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smogorzewski, M.
Right arrow Articles by Massry, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smogorzewski, M.
Right arrow Articles by Massry, S. G.

AJP - Renal Physiology, Vol 258, Issue 4 1036-F1041, Copyright © 1990 by American Physiological Society


ARTICLES

Verapamil corrects abnormalities in norepinephrine metabolism of brain synaptosomes in CRF

M. Smogorzewski, A. Islam, R. Minasian, A. R. Soliman and S. G. Massry
Division of Nephrology, University of Southern California, School of Medicine, Los Angeles 90033.

Abnormalities in norepinephrine (NE) metabolism of brain synaptosomes occur in chronic renal failure (CRF), and this has been attributed to the parathyroid hormone (PTH)-induced accumulation of calcium in synaptosomes. The present study examined the effect of treatment with the calcium-channel blocker verapamil on NE content, release, and uptake, on Na(+)-K(+)-ATPase activity, and on calcium content of brain synaptosomes from rats with 21 days of CRF. Verapamil treatment of normal rats for 21 days did not affect synaptosomal NE content, release, or uptake, Na(+)-K(+)-ATPase activity, or calcium content. Rats with 21 days of CRF displayed a significant (P less than 0.01) reduction in their synaptosomal NE content, release, and uptake, an increase in Na(+)-K(+)-ATPase activity, and a significant (P less than 0.01) increase in calcium content of synaptosomes. The treatment of CRF rats with verapamil normalized synaptosomal NE content and release and Na(+)-K(+)-ATPase activity, produced a significant (P less than 0.01) improvement in NE uptake, and prevented the accumulation of calcium in synaptosomes. The data of the present study are consistent with the notion that the abnormalities in synaptosomal NE metabolism and Na(+)-K(+)-ATPase in CRF are mainly the result of PTH-induced accumulation of calcium in synaptosomes and could be prevented by a calcium-channel blocker.


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
F. SCHAEFER, M. VOGEL, G. KERKHOFF, J. WOITZIK, M. DASCHNER, and O. MEHLS
Experimental Uremia Affects Hypothalamic Amino Acid Neurotransmitter Milieu
J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1218 - 1227.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
D. P. QING, H. DING, J. VADGAMA, Y. Y. WU, and J. D. KOPPLE
Elevated Myocardial Cytosolic Calcium Impairs Insulin-Like Growth Factor-1-Stimulated Protein Synthesis in Chronic Renal Failure
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 84 - 92.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online